supply of - amiodarone injection , adenosine injection , butorphanol injection , carboprost injection , dopamine injection , esmolol injection , pentazocin injection , hyaluronidase injection , labetalol injection , lox lignocaine topical solution , inj.levobupivacaine dextrose , magnesium sulphate injection , mephentermine injection , glycopyrrolate -neostigmine injection , injection methyergometrine , nitroglycerin injection , oxytocin injection , promethazine , sugammadex , korsoplus dodecylb

Employees State Insurance Corporation has invited bids for the supply of - amiodarone injection , adenosine injection , butorphanol injection , carboprost injection , dopamine injection , esmolol injection , pentazocin injection , hyaluronidase injection , labetalol injection , lox lignocaine topical solution , inj.levobupivacaine dextrose , magnesium sulphate injection , mephentermine injection , glycopyrrolate -neostigmine injection , injection methyergometrine , nitroglycerin injection , oxytocin injection , promethazine , sugammadex , korsoplus dodecylbispropylenetriamine didecyldimethylammonium chloride fogging solution , inj.valethamate , inj. hydroxyprogesterone caproate , inj. ethamsylate , inj. phytomenodione , inj. placentrex , inj. lorazepam , inj.torasemide , inj. vitcofol folic acid cyanocobalamin nicotinamide , inj. ofloxacin 200 mg , tab.orciprenaline 10 mg , inj. vasopressin 20 unit per ml , inj. glutathion 600mg , inj. thiamine , inj. streptomycin 500mg , tab. rececadotril 100 mg , tab. norethesterone 5 mg , inj. phenobarbitone , syp. triclofos , oxymetazoline hydrochloride nasal drop , syp. ursodeoxycholic acid , syp. omnacortil , syp. linezolid , syp. racecadotril , inj. tetnus toxoid , inj. clonidine , eye drop homatropine bromide , eye drop flurbiprofen , eye drop repasudil , eye drop hypersol sodium chloride 5 percent , eye ointment hypersol sodium chloride 6 percent , inj. etophylline and theophylline , glycopyrrolate inhalation25 mcg , buprenorphine transdermal patch , human milk fortifier , syp. l- ornithine l- aspartate - medicine 2026 | quantity - 39104. The estimated project cost is ₹0.28 Cr, with an EMD of ₹0.01 Cr. Interested bidders can submit applications until 19 September 2026, with the technical opening scheduled for 19 September 2026.